Patents by Inventor Siva L. S. Velivelli

Siva L. S. Velivelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIMICROBIAL NCR2 PEPTIDES
    Publication number: 20220098249
    Abstract: Antimicrobial nodule specific cysteine rich (NCR2) peptides and proteins are disclosed along with compositions comprising the NCR2 peptides or NCR2 proteins and transgenic or genetically edited plants or microorganisms that express the NCR2 peptides or proteins to inhibit growth of pathogenic microbes. Such NCR2 peptides, proteins, compositions, plants, and microorganisms can provide for inhibition of fungal and oomycete growth.
    Type: Application
    Filed: February 7, 2020
    Publication date: March 31, 2022
    Inventors: Dilip M. Shah, Siva L.S. Velivelli
  • ANTIMICROBIAL PEPTIDES
    Publication number: 20220089661
    Abstract: Antimicrobial OeDef1-, MtDef6-, or OeDef7-type peptides and proteins are disclosed along with compositions comprising the OeDef1-, MtDef6-, or OeDef7-type peptides and proteins and transgenic or genetically edited plants or microorganisms that express the OeDef1-, MtDef6-, or OeDef7-type peptides and proteins to inhibit growth of pathogenic microbes. Such OeDef1-, Mt-Def6-, or OeDef7-type peptides and proteins, compositions, plants, and microorganisms can provide for inhibition of microbial growth.
    Type: Application
    Filed: January 7, 2020
    Publication date: March 24, 2022
    Inventors: Hui Li, Dilip M. Shah, Siva L.S. Velivelli
  • ANTIMICROBIAL NCR PEPTIDES
    Publication number: 20220061333
    Abstract: Antimicrobial nodule specific cysteine rich (NCR) peptides and proteins are disclosed along with compositions comprising the NCR peptides or NCR proteins and transgenic or genetically edited plants or microorganisms that express the NCR peptides or proteins to inhibit growth of pathogenic microbes. Such NCR peptides, proteins, compositions, plants, and microorganisms can provide for inhibition of fungal and oomycete growth.
    Type: Application
    Filed: January 7, 2020
    Publication date: March 3, 2022
    Inventors: Dilip M. Shah, Siva L. S. Velivelli